Submission Information

ABSTRACT SUBMISSIONS CLOSE 12PM ET JANUARY 20
Gain unparalleled exposure for your research and network with global key opinion leaders and decision-makers including C-suite, directors, and managers of leading organizations and labs in the cell and gene therapy space.

Submit Now

THREE WAYS TO SHOWCASE YOUR WORK!

POSTER HALL

ISCT 2025 New Orleans will feature a large Poster Hall open to delegates throughout the meeting.

In addition, ISCT will host two dedicated poster networking receptions during which all meeting delegates gather in the Poster Hall to review research, discuss findings and network with presenters.

ORAL PRESENTATIONS

72 high-scoring abstracts will be invited to give a 10-minute presentation of their work at one of the 8 oral abstract sessions. 

Oral abstract sessions are well-attended attracting over 200 delegates per session.

ELEVATOR PITCH

Thirty high-scoring abstracts will be invited to present their abstract as an elevator pitch and compete for the Best Elevator Pitch Award.

Presenters will have 2 minutes to summarize their research and its impact on the field.

WHY PRESENT AT ISCT?

A Truly Translational Focus on a Global Platform
Whether you focus on basic science and preclinical studies, clinical investigations, manufacturing, regulatory, quality, policy, ethics, or commercialization, your work is vital to advancing the field of cell and gene therapy. ISCT is the place for you to discuss your research with a global community of experts across the translation field.    

Showcase Your Research  - Get Feedback, Collaborate
Be considered for an oral abstract, elevator pitch presentation, or poster presentation and promote your work to global leaders in the cell and gene therapy sector.  Gain exposure to key opinion leaders, potential collaborators, future employers, and expand your professional network.   

Publish Your Work
Accepted abstracts will be published in a special supplement of Cytotherapy, the official journal of ISCT, providing an excellent opportunity to showcase your work to a global translational audience. Many studies first presented at ISCT Annual Meetings go on to be published as full-length articles.

Qualify for Awards
Outstanding abstracts are recognized across multiple categories. With $38,000 in available monetary awards, ISCT is supporting the attendance and participation of abstract submitters across multiple disciplines and representing various sectors of our field.

Launch Your Career
ISCT is invested in the future of our sector and has created exclusive opportunities for Early Stage Professionals to present their work at ISCT 2025. Students, recent grads, and postdocs are encouraged to submit.

ABSTRACT CATEGORIES

  • Mesenchymal Stem/Stromal Cells
  • Hematopoietic Stem/Progenitor Cells and Engineering
  • Immunotherapy (CAR-T, T Reg, NK Cells etc.)
  • Exosomes/EVs
  • iPSC
  • Gene Editing/Gene Therapies (AAVs, LNPs, nucleotide-based therapies)
  • Tissue Engineering
  • Embryonic, Organ and Other Tissue Specific Stem Cells
  • Process Development and Manufacturing
  • Regulatory Affairs, Quality Systems, Policy, Ethics, and Patient Access

Full List of Abstract Categories

KEY DATES


ABSTRACT SUBMISSION CLOSES
January 20, 2025
12PM ET

NOTIFICATION OF ACCEPTANCE
February 7, 2025

ACCEPTED ABSTRACT RSVP AND REGISTRATION DEADLINE
February 24, 2025

ENGAGE THE CGT COMMUNITY

ABSTRACT AWARDS

General eligibility criteria:

  1. Recipient must hold current 2025 ISCT membership.
  2. Recipient must present the abstract in-person at ISCT 2025 New Orleans.
  3. Recipient cannot win multiple awards.
  1. Recipient must hold current 2025 ISCT membership.
  2. Recipient must present the abstract in-person at ISCT 2025 New Orleans.
  3. Recipient cannot win multiple awards.
STANDING AWARDS

1 Available | Sponsor: Cytotherapy

The Top Scoring Abstract Award recognizes outstanding abstract submissions across the field of cell and gene therapy translation. This award is given to the abstract receiving the top score through our blinded-review process.

  • Specific Eligibility Criteria: None

1 Available | Sponsor: ISCT

The Best Poster Award is voted on by the ISCT 2025 New Orleans Planning Faculty. It recognizes the best poster being presented in terms of the quality of the research and the quality of the display and messaging.

  • Specific Eligibility Criteria: Recipient must present a poster at ISCT 2025 New Orleans.

1 Available | Sponsor: Cytotherapy

The ISCT 2025 Organizing Committee will attend the Elevator Pitch Competition and vote on the presentation that most effectively communicates a concise and comprehensive overview of the presenter's research within the alloted two minutes.

  • Specific Eligibility Criteria: Recipient must be an invited participant in the Elevator Pitch Competition.

3 Available | Sponsor: ISCT

The Early Stage Professionals Awards recognize outstanding research submitted by Early Stage Professionals.

  • Specific Eligibility Criteria: Presenter must be an Early Stage Professional. Early Stage Professionals are classified as students or professionals within ten years of their terminal degree or entry into the field of cell and gene therapy.

3 Available | Sponsor: ISCT

ISCT recognizes that research and innovation begins at "the bench" and have established the Technologist Awards to celebrate impactful submissions from laboratory technicians.

  • Specific Eligibility Criteria: Recipient must be a laboratory technician and be employed in technical laboratory settings (laboratory directors and upper management are not eligible). Laboratory technicians typically hold a technical designation (e.g., MLS(ASCP) or equivalent).

1 Available | Sponsor: Cytotherapy

The Emerging Economy Abstract Award is granted to the top scoring abstract being presented by an author residing in a developing economy.

  • Specific Eligibility Criteria: Recipient must reside in a low-income or middle-income economy (LMIC) as defined by the World Bank.

REGIONAL AWARDS

1 Available | Sponsor: ISCT Asia Regional Executive Committee

Recognizes the highest scoring abstract submitted by a presenter residing in Asia. 

  • Specific Eligibility Criteria: Recipient must reside in Asia.

1 Available | Sponsor: ISCT South & Central America Regional Executive Committee

The Top Scoring South & Central America Abstract Award recognizes outstanding contributions in CGT research within the South and Central America region. This award serves as a platform to acknowledge and promote the exceptional work of individuals who are making noteworthy strides within the dynamic landscapes of the South and Central America region.

1 Available | Sponsor: ISCT Europe Regional Executive Committee

Recognizes the highest scoring abstract submitted by a presenter residing in Europe.

  • Specific Eligibility Criteria: Recipient must reside in Europe.

1 Available | Sponsor: ISCT Australia & New Zealand Regional Executive Committee

Recognizes the highest scoring abstract submitted by a presenter residing in Australia or New Zealand. 

  • Specific Eligibility Criteria: Recipient must reside in Australia or New Zealand.

12 Available: 4  Eastern, 4 Central, 4 Western

These awards serve to highlight outstanding research and technological developments across the United States, host country for ISCT 2025.

  • Specific Eligibility Criteria: Recipient must reside in United States.
SCIENTIFIC AWARDS

1 Award of $1,000
2 Awards of $500

Sponsor: ISCT

The iPSC Abstract Awards are designed to recognize outstanding abstracts related to induced Pluripotent Stem Cells (iPSC) research. iPSCs have emerged as an area of immense potential in disease modeling, drug discovery, and therapeutics, and this award aims to highlight and support innovative contributions in this growing clinical field.

  • Specific Eligibility Criteria: Abstract must have been submitted in 'iPSC' abstract category.

1 Award of $1,000
2 Awards of $500

Sponsor: ISCT Stem Cell Engineering Committee

The Stem Cell Engineering Abstract Awards aim to recognize outstanding contributions in the field of stem cell engineering. These awards are designed to highlight innovative and impactful research in the application of engineering principles to the study, manipulation, and application of stem cells. The awarded abstracts should demonstrate significant advancements, novel approaches, or breakthroughs that contribute to the progress of stem cell research and its applications.

  • Specific Eligibility Criteria: None.

1 Award of $1,000
2 Awards of $500

Sponsor: ISCT

The Top Scoring Emerging Immunotherapy Abstract Awards recognizes the latest immunotherapy research. This award is designed to support and promote advancements in the translation of novel immunotherapies, with the goal of bringing these new technologies from bench to bedside

  • Specific Eligibility Criteria: Abstract must have been submitted in 'Immunotherapy (CAR-T, T Reg, NK Cells etc.)' abstract category.

1 Award of $1,000
2 Awards of $500

Sponsor: ISCT

The Top Scoring Exosome Abstract Awards are designed to recognize outstanding abstracts related to Exosomes/Extracellular Vesicles (EVs) research. Exosomes have emerged as an area of immense potential for their applications in immune modulation, control of lymphocyte proliferation and many other therapeutic uses. This award aims to highlight and support innovative contributions in this growing clinical field.

  • Specific Eligibility Criteria: Abstract must have been submitted in 'Exosomes/EVs' abstract category.

COMMERCIALIZATION AWARDS

2 Available

Enabler: The highest scoring abstract submitted by a young, emerging “Start-Up” company pursuing an innovative technology solution that will disrupt the sector’s current practices. This award recognizes groundbreaking ideas that demonstrate both ingenuity and potential for significant impact, driving progress and setting new standards within the industry. The winning submission will embody forward-thinking approaches that challenge traditional methods, offering a transformative vision for the future of the sector.

Therapeutic: The highest scoring abstract submitted by a young, emerging “Start-Up” company pursuing therapeutic product with clinical potential. The winning submission will exemplify breakthrough thinking and a commitment to advancing new treatments that address unmet medical needs, with a clear pathway toward clinical application and patient benefit

Specific Eligibility Criteria for the Start-Up Abstract Award:

  • Must be incorporated in or after 2020
  • Must have fewer than 25 Full-Time Employees at time of submission

1 Available

The highest scoring abstract in Artificial Intelligence & Machine Learning for Cell and Gene Therapy recognizes pioneering research that leverages AI/ML to advance the field of cell and gene therapies. This award is designed to support and promote innovations in AI/ML-driven methodologies that enhance the precision, scalability, and effectiveness of cell and gene therapies.

GUIDELINES AND POLICIES

  • The abstract body cannot exceed 2500 characters, exclusive of the title, author block, images, and tables.

  • Note that spaces count as characters.

  • Ensure that any references to licensed products are labelled with their non-proprietary names.

  • Abstracts must be submitted via the online Abstract Submission System. Abstracts will NOT be accepted by email, mail, or fax.

  • There are limited opportunities for oral talks. Invitations to give an oral presentation are based on the quality and scope of the submitted abstract as determined through our blinded-review process.

  • The inclusion of all relevant data to your topic is strongly encouraged as Reviewers will evaluate this when scoring submitted abstracts.

  • ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn no later than February 24th, 2025. If not withdrawn by this deadline, all accepted abstracts will be published in the final program and abstract supplement.

  • Abstract presenters must have FULL conference registration to present at the meeting.

  • All accepted abstracts are subject to the ISCT Embargo Policy until April 30, 2025.
  • Abstracts submitted to the ISCT 2025 Annual Meeting are embargoed from the time of submission until April 30th, 2025.

  • For the abstract to be eligible for presentation at the ISCT 2025 Annual Meeting, information contained within, as well as additional data and information to be presented about the content, may not be published elsewhere or made public before the abstract has been published/presented at the ISCT 2025 Annual Meeting.

  • Authors must notify ISCT if, after the submission deadline, the submitted abstract is accepted for publication elsewhere and will be published before the ISCT 2025 Annual Meeting. Publication before the meeting may result in the abstract being removed from the conference.

  • If the Embargo Policy is violated, the abstract may be withdrawn by ISCT from presentation at the ISCT 2025 Annual Meeting and from publication in the abstract supplement.

*An embargo means that information from any abstract or presentation may not be
announced, publicized, or distributed before the embargo date and time.

ISCT generally does not accept encore abstracts unless there are substantial data updates. However, exceptions may be granted upon written request to jan@isctglobal.org, provided your request includes a clear justification for the encore abstract (e.g. if the ISCT audience significantly differs from the initial presentation).

* An encore abstract is the resubmission of an original abstract
that has previously been presented at another conference